Drug Shortage Report for BIVALIRUDIN INJECTION
Report ID | 253968 |
Drug Identification Number | 02505517 |
Brand name | BIVALIRUDIN INJECTION |
Common or Proper name | Bivalirudin Injectable 250mg/50mL 10vials |
Company Name | AVIR PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BIVALIRUDIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10 |
ATC code | B01AE |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2025-04-02 |
Actual start date | |
Estimated end date | 2025-04-18 |
Actual end date | 2025-04-23 |
Shortage status | Resolved |
Updated date | 2025-04-24 |
Company comments | We still have inventory, but only shortdated inventory |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2025-04-24 | English | Compare |
v5 | 2025-04-23 | French | Compare |
v4 | 2025-04-23 | English | Compare |
v3 | 2025-04-03 | English | Compare |
v2 | 2025-04-02 | French | Compare |
v1 | 2025-04-02 | English | Compare |
Showing 1 to 6 of 6